Triglyceride–glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies

Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride-glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people...

Full description

Saved in:
Bibliographic Details
Published inCardiovascular diabetology Vol. 20; no. 1; pp. 76 - 13
Main Authors Ding, Xiaobo, Wang, Xiaozhen, Wu, Jing, Zhang, Manli, Cui, Meizi
Format Journal Article
LanguageEnglish
Published England BioMed Central 03.04.2021
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride-glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis. Cohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results. Eight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29-2.01, I  = 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18-1.64, I  = 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47-2.58, I  = 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23-1.29, I  = 0%, P < 0.001). A higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline.
AbstractList Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride-glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis.BACKGROUNDInsulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride-glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis.Cohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results.METHODSCohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results.Eight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29-2.01, I2 = 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18-1.64, I2 = 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47-2.58, I2 = 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23-1.29, I2 = 0%, P < 0.001).RESULTSEight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29-2.01, I2 = 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18-1.64, I2 = 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47-2.58, I2 = 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23-1.29, I2 = 0%, P < 0.001).A higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline.CONCLUSIONSA higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline.
Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride-glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis. Cohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results. Eight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29-2.01, I  = 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18-1.64, I  = 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47-2.58, I  = 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23-1.29, I  = 0%, P < 0.001). A higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline.
Abstract Background Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride–glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis. Methods Cohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results. Results Eight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29–2.01, I2 = 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18–1.64, I2 = 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47–2.58, I2 = 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23–1.29, I2 = 0%, P < 0.001). Conclusions A higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline.
Background Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the association between the triglyceride–glucose (TyG) index, a novel surrogate indicator of insulin resistance, and the incidence of ASCVDs in people without ASCVDs at baseline by performing a meta-analysis. Methods Cohort studies reporting the multivariate-adjusted association between the TyG index and the incidence of ASCVDs were obtained by searching the PubMed and Embase databases. A random-effects model incorporating intra-study heterogeneity was applied to combine the results. Results Eight cohort studies comprising 5,731,294 participants were included in this meta-analysis. The results showed that compared to those with the lowest TyG index category, participants with the highest TyG index category were independently associated with a higher risk of ASCVDs [hazard ratio (HR): 1.61, 95% confidence interval (CI) 1.29–2.01, I2 = 80%, P < 0.001]. This finding was consistent with the meta-analysis results with the TyG index analyzed as a continuous variable (HR per 1-unit increment of the TyG index: 1.39, 95% CI 1.18–1.64, I2 = 89%, P < 0.001). Subgroup analyses suggested that the age, sex, and diabetic status did not significantly affect the association (for subgroup analyses, all P > 0.05). Moreover, participants with the highest TyG index category were independently associated with a higher risk of coronary artery disease [(CAD), HR: 1.95, 95% CI 1.47–2.58, I2 = 92%, P < 0.001] and stroke (HR: 1.26, 95% CI 1.23–1.29, I2 = 0%, P < 0.001). Conclusions A higher TyG index may be independently associated with a higher incidence of ASCVDs, CAD, and stroke in people without ASCVDs at baseline.
ArticleNumber 76
Author Wu, Jing
Ding, Xiaobo
Wang, Xiaozhen
Cui, Meizi
Zhang, Manli
Author_xml – sequence: 1
  givenname: Xiaobo
  surname: Ding
  fullname: Ding, Xiaobo
– sequence: 2
  givenname: Xiaozhen
  surname: Wang
  fullname: Wang, Xiaozhen
– sequence: 3
  givenname: Jing
  surname: Wu
  fullname: Wu, Jing
– sequence: 4
  givenname: Manli
  surname: Zhang
  fullname: Zhang, Manli
– sequence: 5
  givenname: Meizi
  surname: Cui
  fullname: Cui, Meizi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33812373$$D View this record in MEDLINE/PubMed
BookMark eNp9UsluFDEQbaEgssAPcEAtceHS4LLdizkgoYglUiQu4WxV29UzHnnawe6OMhIH_oE_5EtwZxKU5IAPXqreey673nFxMIaRiuIlsLcAXfMuAVdCVIxDxYA3XaWeFEcg27rinWQH9_aHxXFKG8ag7Rp4VhwK0QEXrTgqfl5Et_I7Q9FZ-vPr98rPJiQq3WjpusTRltN6OZmcHg2VYSgxR2JIxud5cqY0GK0LV5jM7DGW1iXCROl9ieWWJqxwRL9LLi1cE9YhTmWaZusoPS-eDugTvbhdT4rvnz9dnH6tzr99OTv9eF6ZhqupagxTfd9ZprCRNTBJkoSFTgpgJCVxqgdlgNecWWMkF7zvDUcUrKWmblGcFGd7XRtwoy-j22Lc6YBO3wRCXGmM-SmeNAMzNGQUtExJZANayBcINfRgWF3brPVhr3U591uyhsYpon8g-jAzurVehSvdMVA1gyzw5lYghh8zpUlvXTLkPY4U5qR5zbo8uJAZ-voRdBPmmL9zQYHkDW-gzahX9yv6V8pdkzOg2wNMbluKNGjjJpxcWAp0XgPTi5_03k86-0nf-EmrTOWPqHfq_yH9BbXd0DE
CitedBy_id crossref_primary_10_3389_fcvm_2022_895609
crossref_primary_10_1186_s12891_023_06700_7
crossref_primary_10_1016_j_vhri_2023_05_001
crossref_primary_10_1038_s41598_024_81967_x
crossref_primary_10_1186_s12933_024_02124_2
crossref_primary_10_46332_aemj_1140228
crossref_primary_10_3389_fmed_2024_1328601
crossref_primary_10_1186_s12933_024_02437_2
crossref_primary_10_3389_fcvm_2021_704462
crossref_primary_10_12677_ACM_2023_1371599
crossref_primary_10_1007_s10554_024_03048_4
crossref_primary_10_1007_s12020_024_04037_2
crossref_primary_10_3389_fcvm_2022_1002030
crossref_primary_10_18632_aging_205710
crossref_primary_10_3389_fendo_2022_889379
crossref_primary_10_1093_eurjpc_zwad340
crossref_primary_10_2174_1567202620666230606100652
crossref_primary_10_1016_S2666_7568_22_00247_1
crossref_primary_10_1186_s12933_023_02001_4
crossref_primary_10_3389_fcvm_2022_832491
crossref_primary_10_1186_s12933_023_01864_x
crossref_primary_10_7759_cureus_35532
crossref_primary_10_7759_cureus_65546
crossref_primary_10_3389_fendo_2024_1423227
crossref_primary_10_12677_ACM_2023_1351096
crossref_primary_10_3389_fcvm_2023_1275710
crossref_primary_10_1007_s00417_024_06376_2
crossref_primary_10_3390_jcm11216419
crossref_primary_10_3389_fcvm_2024_1517437
crossref_primary_10_1186_s12967_023_04159_7
crossref_primary_10_1186_s12933_022_01617_2
crossref_primary_10_12677_ACM_2024_142440
crossref_primary_10_1111_1753_0407_13312
crossref_primary_10_2196_47095
crossref_primary_10_1155_2022_5125884
crossref_primary_10_1007_s12012_024_09913_x
crossref_primary_10_1055_a_1853_9889
crossref_primary_10_1186_s12902_022_01180_7
crossref_primary_10_1016_j_jdiacomp_2023_108516
crossref_primary_10_1186_s12933_023_01739_1
crossref_primary_10_3389_fendo_2022_817176
crossref_primary_10_31450_ukrjnd_1_77__2023_08
crossref_primary_10_3389_fcvm_2022_994329
crossref_primary_10_1186_s12933_023_02082_1
crossref_primary_10_1186_s12933_023_02100_2
crossref_primary_10_3389_fendo_2024_1416234
crossref_primary_10_1177_10742484231181846
crossref_primary_10_14341_DM13073
crossref_primary_10_1016_j_numecd_2023_10_036
crossref_primary_10_7717_peerj_18781
crossref_primary_10_7759_cureus_39034
crossref_primary_10_1016_j_surg_2024_07_034
crossref_primary_10_1186_s12933_022_01704_4
crossref_primary_10_3389_fendo_2024_1357580
crossref_primary_10_3390_ijms26010334
crossref_primary_10_1186_s12933_022_01694_3
crossref_primary_10_1186_s12933_022_01546_0
crossref_primary_10_1093_ckj_sfac084
crossref_primary_10_1186_s12877_024_05002_4
crossref_primary_10_3389_fendo_2022_1023867
crossref_primary_10_1186_s12933_022_01523_7
crossref_primary_10_1186_s12933_024_02510_w
crossref_primary_10_1186_s12888_022_04434_9
crossref_primary_10_1038_s41598_024_75887_z
crossref_primary_10_1093_eurjpc_zwac058
crossref_primary_10_1210_clinem_dgad089
crossref_primary_10_1590_s0004_2803_230302023_44
crossref_primary_10_1177_03000605231164548
crossref_primary_10_1016_j_avsg_2023_08_013
crossref_primary_10_1186_s12933_023_01906_4
crossref_primary_10_1186_s12933_022_01453_4
crossref_primary_10_1007_s00592_024_02322_0
crossref_primary_10_1177_10815589231152823
crossref_primary_10_1093_ckj_sfac073
crossref_primary_10_1186_s12933_023_01823_6
crossref_primary_10_3389_fendo_2024_1437711
crossref_primary_10_1186_s12933_024_02165_7
crossref_primary_10_1155_2023_1966680
crossref_primary_10_1186_s12933_024_02241_y
crossref_primary_10_3389_fcvm_2023_1242035
crossref_primary_10_1186_s12877_023_03788_3
crossref_primary_10_1111_eci_70013
crossref_primary_10_1007_s10792_024_03344_x
crossref_primary_10_1186_s12933_022_01695_2
crossref_primary_10_1055_a_2266_1503
crossref_primary_10_1177_00033197221124763
crossref_primary_10_3390_jcm11164644
crossref_primary_10_1186_s12933_023_02110_0
crossref_primary_10_1186_s12944_023_01925_w
crossref_primary_10_5334_gh_1303
crossref_primary_10_1186_s12889_025_22085_9
crossref_primary_10_12677_ACM_2022_124515
crossref_primary_10_1007_s10067_024_06884_w
crossref_primary_10_1186_s12933_022_01683_6
crossref_primary_10_1186_s12933_023_02080_3
crossref_primary_10_1038_s41598_023_33294_w
crossref_primary_10_26599_1671_5411_2023_03_001
crossref_primary_10_1186_s12933_021_01342_2
crossref_primary_10_1055_a_2354_3573
crossref_primary_10_1186_s12933_022_01658_7
crossref_primary_10_1186_s12933_024_02457_y
crossref_primary_10_1016_j_diabres_2021_109073
crossref_primary_10_3389_fendo_2023_1302127
crossref_primary_10_2147_CLEP_S457054
crossref_primary_10_1016_j_bbrc_2022_06_082
crossref_primary_10_1186_s12902_025_01834_2
crossref_primary_10_1186_s12933_023_01883_8
crossref_primary_10_3389_fcvm_2024_1396865
crossref_primary_10_1055_a_2279_7112
crossref_primary_10_2147_JHC_S454037
crossref_primary_10_1186_s13098_024_01423_8
crossref_primary_10_1016_j_cjco_2025_01_005
crossref_primary_10_3389_fendo_2022_1015747
crossref_primary_10_1186_s12933_023_01939_9
crossref_primary_10_1186_s12933_023_02054_5
crossref_primary_10_1097_MD_0000000000033194
crossref_primary_10_1186_s12872_024_04450_5
crossref_primary_10_61411_rsc202590418
crossref_primary_10_3389_fendo_2023_1282675
crossref_primary_10_3389_fendo_2024_1290226
crossref_primary_10_3389_fendo_2025_1510493
crossref_primary_10_1186_s12933_025_02693_w
crossref_primary_10_3389_fcvm_2024_1429993
crossref_primary_10_1186_s12933_023_02089_8
crossref_primary_10_1186_s12933_023_01834_3
crossref_primary_10_3389_fnut_2025_1539969
crossref_primary_10_1016_j_numecd_2023_02_005
crossref_primary_10_1186_s12889_024_20551_4
crossref_primary_10_1186_s12933_025_02585_z
crossref_primary_10_3389_fendo_2024_1444800
crossref_primary_10_1186_s13098_023_01181_z
crossref_primary_10_1186_s12933_025_02668_x
crossref_primary_10_1186_s12933_022_01599_1
crossref_primary_10_1186_s12933_025_02584_0
crossref_primary_10_1002_ehf2_14679
crossref_primary_10_3389_fcdhc_2022_1101276
crossref_primary_10_1177_10760296221094030
crossref_primary_10_1186_s12933_025_02683_y
crossref_primary_10_1111_cen_15171
crossref_primary_10_3174_ajnr_A8144
crossref_primary_10_1016_j_amepre_2025_01_022
crossref_primary_10_1186_s12933_021_01332_4
crossref_primary_10_1080_10641963_2022_2150204
crossref_primary_10_3389_fendo_2023_1187381
crossref_primary_10_7570_jomes23055
crossref_primary_10_1038_s41387_024_00295_1
crossref_primary_10_1186_s12933_023_02113_x
crossref_primary_10_4239_wjd_v15_i6_1242
crossref_primary_10_1161_JAHA_123_030022
crossref_primary_10_1016_j_numecd_2025_103963
crossref_primary_10_1186_s12933_022_01541_5
crossref_primary_10_1186_s12933_024_02193_3
crossref_primary_10_1186_s12944_022_01732_9
crossref_primary_10_3389_fendo_2023_1259062
crossref_primary_10_1016_j_ahj_2022_02_014
crossref_primary_10_1186_s12933_024_02230_1
crossref_primary_10_1016_j_ijcrp_2024_200250
crossref_primary_10_1186_s12933_024_02423_8
crossref_primary_10_1002_VIW_20240059
crossref_primary_10_1038_s41598_023_41546_y
crossref_primary_10_3389_fcvm_2021_774781
crossref_primary_10_3389_fcvm_2024_1397907
crossref_primary_10_1097_MD_0000000000039256
crossref_primary_10_3389_fendo_2022_1077632
crossref_primary_10_1186_s12933_025_02641_8
crossref_primary_10_2147_IJWH_S387942
crossref_primary_10_1111_odi_14420
crossref_primary_10_1038_s41598_024_84278_3
crossref_primary_10_1186_s12944_025_02508_7
crossref_primary_10_3389_fcvm_2022_1019233
crossref_primary_10_1097_GME_0000000000002374
crossref_primary_10_1016_j_numecd_2022_11_004
crossref_primary_10_1038_s41598_024_78056_4
crossref_primary_10_1186_s12933_023_02115_9
crossref_primary_10_12677_acm_2025_151146
crossref_primary_10_2147_IJGM_S350474
crossref_primary_10_3390_jcm14030950
crossref_primary_10_1186_s12902_025_01900_9
crossref_primary_10_1186_s12933_024_02390_0
crossref_primary_10_20996_1819_6446_2024_3035
crossref_primary_10_3389_fendo_2021_761397
crossref_primary_10_1186_s12933_022_01472_1
crossref_primary_10_2147_DMSO_S385906
crossref_primary_10_1177_14791641221113784
crossref_primary_10_1186_s13098_024_01306_y
crossref_primary_10_1080_10641963_2024_2383232
crossref_primary_10_1080_10641963_2024_2341631
crossref_primary_10_1055_a_1766_0202
crossref_primary_10_1186_s12944_024_02394_5
crossref_primary_10_1007_s12291_022_01083_3
crossref_primary_10_1186_s12933_024_02392_y
crossref_primary_10_1186_s12986_024_00802_2
crossref_primary_10_1186_s12933_023_02038_5
crossref_primary_10_3389_fcvm_2022_1035105
crossref_primary_10_1007_s11357_023_01044_5
crossref_primary_10_1186_s12933_023_02016_x
crossref_primary_10_3389_fnut_2024_1475204
crossref_primary_10_1161_HYPERTENSIONAHA_124_23087
crossref_primary_10_1186_s12933_022_01649_8
crossref_primary_10_1186_s12944_023_01773_8
crossref_primary_10_3389_fcvm_2024_1363049
crossref_primary_10_3390_metabo14120651
crossref_primary_10_1016_j_diabres_2024_111640
crossref_primary_10_3389_fendo_2024_1471535
crossref_primary_10_1136_bmjopen_2023_081131
crossref_primary_10_1186_s12944_025_02486_w
crossref_primary_10_1186_s12933_023_01870_z
crossref_primary_10_3390_diagnostics15040494
crossref_primary_10_1111_jch_14758
crossref_primary_10_1186_s12933_023_01779_7
crossref_primary_10_3389_fendo_2023_1148203
crossref_primary_10_1152_ajpheart_00684_2024
crossref_primary_10_1038_s41598_025_93922_5
crossref_primary_10_1186_s12933_023_02004_1
Cites_doi 10.1007/s11886-020-01332-y
10.1038/s41598-019-43776-5
10.3390/nu11112838
10.1016/j.arcmed.2015.06.006
10.1186/s12933-019-0982-2
10.12997/jla.2019.8.2.173
10.1210/jc.2010-0288
10.1210/er.2018-00141
10.1186/s12933-020-01210-5
10.1186/s12933-020-01108-2
10.1186/s12944-016-0324-2
10.1089/met.2008.0034
10.1016/j.numecd.2016.12.002
10.1186/s12933-020-01121-5
10.1136/bmj.315.7109.629
10.1016/j.ctim.2020.102531
10.1097/01.hjh.0000194121.19851.e5
10.1111/1753-0407.12970
10.1186/s12916-020-01824-2
10.1186/s12872-020-01496-z
10.1016/j.diabres.2011.05.030
10.1111/j.0894-0959.2004.17311.x
10.1161/JAHA.119.012178
10.1111/eci.12583
10.1038/nrcardio.2009.55
10.2174/1573399810666140214093600
10.1007/s11883-020-00862-8
10.1186/s13098-018-0376-8
10.1001/jama.283.15.2008
10.1007/s11892-019-1178-6
10.1016/j.numecd.2019.09.015
10.1016/j.cmet.2011.07.015
10.1186/s12933-020-01186-2
10.1002/sim.1186
10.1046/j.1464-5491.2003.00869.x
10.1093/ije/dyn065
ContentType Journal Article
Copyright 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID AAYXX
CITATION
NPM
3V.
7T5
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12933-021-01268-9
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Immunology Abstracts
ProQuest Health & Medical Collection (NC LIVE)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1475-2840
EndPage 13
ExternalDocumentID oai_doaj_org_article_01cf6ec917094a0fad14e239fb1c055d
PMC8019501
33812373
10_1186_s12933_021_01268_9
Genre Journal Article
GrantInformation_xml – fundername: Research Fund of the First Hospital of Jilin University
  grantid: 04020940001
– fundername: ;
  grantid: 04020940001
GroupedDBID ---
0R~
29B
2WC
53G
5GY
5VS
6J9
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
-5E
-5G
-A0
-BR
3V.
ACRMQ
ADINQ
C24
FRP
NPM
7T5
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c629t-6c09bb8d09a645104e4e3d184310e44e2e5f9c12520dcc4232bbc2aa307e657a3
IEDL.DBID M48
ISSN 1475-2840
IngestDate Wed Aug 27 01:30:08 EDT 2025
Thu Aug 21 14:33:00 EDT 2025
Tue Aug 05 09:15:03 EDT 2025
Fri Jul 25 02:55:13 EDT 2025
Thu Jan 02 22:56:53 EST 2025
Thu Apr 24 23:10:59 EDT 2025
Tue Jul 01 04:19:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Triglyceride-glucose index
Atherosclerotic cardiovascular diseases
Insulin resistance
Coronary artery disease
Meta-analysis
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c629t-6c09bb8d09a645104e4e3d184310e44e2e5f9c12520dcc4232bbc2aa307e657a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12933-021-01268-9
PMID 33812373
PQID 2514262617
PQPubID 42570
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_01cf6ec917094a0fad14e239fb1c055d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8019501
proquest_miscellaneous_2508888234
proquest_journals_2514262617
pubmed_primary_33812373
crossref_citationtrail_10_1186_s12933_021_01268_9
crossref_primary_10_1186_s12933_021_01268_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-04-03
PublicationDateYYYYMMDD 2021-04-03
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-03
  day: 03
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Cardiovascular diabetology
PublicationTitleAlternate Cardiovasc Diabetol
PublicationYear 2021
Publisher BioMed Central
BMC
Publisher_xml – name: BioMed Central
– name: BMC
References SS Virani (1268_CR1) 2020; 141
PV Thai (1268_CR16) 2020; 19
DN Vikulova (1268_CR6) 2019; 8
F Guerrero-Romero (1268_CR38) 2010; 95
B Park (1268_CR24) 2020; 19
AC Vasques (1268_CR39) 2011; 93
X Tian (1268_CR25) 2021; 20
PD Rosenblit (1268_CR3) 2019; 19
DF Stroup (1268_CR26) 2000; 283
S Beddhu (1268_CR33) 2004; 17
LL Hayman (1268_CR7) 2020; 22
ZT Bloomgarden (1268_CR11) 2006; 26
E Cersosimo (1268_CR12) 2014; 10
S Hong (1268_CR23) 2020; 18
SH Khan (1268_CR13) 2018; 10
1268_CR29
1268_CR27
LE Simental-Mendia (1268_CR28) 2008; 6
WY Su (1268_CR21) 2019; 11
L Sanchez-Inigo (1268_CR19) 2016; 46
MR Salazar (1268_CR20) 2017; 27
A Di Pino (1268_CR8) 2019; 40
EY Lee (1268_CR15) 2016; 15
D Mahtta (1268_CR5) 2020; 22
J Alizargar (1268_CR14) 2020; 19
S Barquera (1268_CR2) 2015; 46
S Li (1268_CR18) 2019; 9
S Choi (1268_CR4) 2019; 8
JK Beverly (1268_CR9) 2020; 12
KE Bornfeldt (1268_CR10) 2011; 14
M Egger (1268_CR32) 1997; 315
N Barzegar (1268_CR22) 2020; 19
NA Patsopoulos (1268_CR31) 2008; 37
AK Poon (1268_CR37) 2020; 20
W Shi (1268_CR17) 2020; 30
JP Higgins (1268_CR30) 2002; 21
VZ Rocha (1268_CR34) 2009; 6
SB Wheatcroft (1268_CR35) 2003; 20
RJ Kaaja (1268_CR36) 2006; 24
M Shahavandi (1268_CR40) 2020; 53
References_xml – volume: 22
  start-page: 86
  year: 2020
  ident: 1268_CR7
  publication-title: Curr Cardiol Rep
  doi: 10.1007/s11886-020-01332-y
– volume: 9
  start-page: 7320
  year: 2019
  ident: 1268_CR18
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-43776-5
– volume: 11
  start-page: 2838
  year: 2019
  ident: 1268_CR21
  publication-title: Nutrients
  doi: 10.3390/nu11112838
– volume: 46
  start-page: 328
  year: 2015
  ident: 1268_CR2
  publication-title: Arch Med Res
  doi: 10.1016/j.arcmed.2015.06.006
– volume: 19
  start-page: 8
  year: 2020
  ident: 1268_CR14
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-019-0982-2
– volume: 8
  start-page: 173
  year: 2019
  ident: 1268_CR4
  publication-title: J Lipid Atheroscler
  doi: 10.12997/jla.2019.8.2.173
– volume: 95
  start-page: 3347
  year: 2010
  ident: 1268_CR38
  publication-title: J Clin Endocrinol Metab.
  doi: 10.1210/jc.2010-0288
– volume: 26
  start-page: vi
  issue: 611–33
  year: 2006
  ident: 1268_CR11
  publication-title: Clin Lab Med
– volume: 40
  start-page: 1447
  year: 2019
  ident: 1268_CR8
  publication-title: Endocr Rev
  doi: 10.1210/er.2018-00141
– volume: 20
  start-page: 19
  year: 2021
  ident: 1268_CR25
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-020-01210-5
– volume: 19
  start-page: 137
  year: 2020
  ident: 1268_CR16
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-020-01108-2
– volume: 15
  start-page: 155
  year: 2016
  ident: 1268_CR15
  publication-title: Lipids Health Dis
  doi: 10.1186/s12944-016-0324-2
– volume: 6
  start-page: 299
  year: 2008
  ident: 1268_CR28
  publication-title: Metab Syndr Relat Disord
  doi: 10.1089/met.2008.0034
– volume: 27
  start-page: 366
  year: 2017
  ident: 1268_CR20
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/j.numecd.2016.12.002
– volume: 19
  start-page: 155
  year: 2020
  ident: 1268_CR22
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-020-01121-5
– ident: 1268_CR27
– volume: 315
  start-page: 629
  year: 1997
  ident: 1268_CR32
  publication-title: BMJ
  doi: 10.1136/bmj.315.7109.629
– volume: 53
  start-page: 102531
  year: 2020
  ident: 1268_CR40
  publication-title: Complement Ther Med
  doi: 10.1016/j.ctim.2020.102531
– volume: 24
  start-page: 131
  year: 2006
  ident: 1268_CR36
  publication-title: J Hypertens
  doi: 10.1097/01.hjh.0000194121.19851.e5
– volume: 12
  start-page: 102
  year: 2020
  ident: 1268_CR9
  publication-title: J Diabetes
  doi: 10.1111/1753-0407.12970
– volume: 18
  start-page: 361
  year: 2020
  ident: 1268_CR23
  publication-title: BMC Med
  doi: 10.1186/s12916-020-01824-2
– ident: 1268_CR29
– volume: 20
  start-page: 217
  year: 2020
  ident: 1268_CR37
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/s12872-020-01496-z
– volume: 93
  start-page: e98
  year: 2011
  ident: 1268_CR39
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2011.05.030
– volume: 17
  start-page: 229
  year: 2004
  ident: 1268_CR33
  publication-title: Semin Dial
  doi: 10.1111/j.0894-0959.2004.17311.x
– volume: 8
  start-page: e012178
  year: 2019
  ident: 1268_CR6
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.119.012178
– volume: 46
  start-page: 189
  year: 2016
  ident: 1268_CR19
  publication-title: Eur J Clin Invest
  doi: 10.1111/eci.12583
– volume: 6
  start-page: 399
  year: 2009
  ident: 1268_CR34
  publication-title: Nat Rev Cardiol
  doi: 10.1038/nrcardio.2009.55
– volume: 10
  start-page: 2
  year: 2014
  ident: 1268_CR12
  publication-title: Curr Diabetes Rev
  doi: 10.2174/1573399810666140214093600
– volume: 22
  start-page: 44
  year: 2020
  ident: 1268_CR5
  publication-title: Curr Atheroscler Rep
  doi: 10.1007/s11883-020-00862-8
– volume: 10
  start-page: 74
  year: 2018
  ident: 1268_CR13
  publication-title: Diabetol Metab Syndr
  doi: 10.1186/s13098-018-0376-8
– volume: 283
  start-page: 2008
  year: 2000
  ident: 1268_CR26
  publication-title: JAMA
  doi: 10.1001/jama.283.15.2008
– volume: 19
  start-page: 61
  year: 2019
  ident: 1268_CR3
  publication-title: Curr Diab Rep
  doi: 10.1007/s11892-019-1178-6
– volume: 30
  start-page: 245
  year: 2020
  ident: 1268_CR17
  publication-title: Nutr Metab Cardiovasc Dis
  doi: 10.1016/j.numecd.2019.09.015
– volume: 14
  start-page: 575
  year: 2011
  ident: 1268_CR10
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2011.07.015
– volume: 19
  start-page: 210
  year: 2020
  ident: 1268_CR24
  publication-title: Cardiovasc Diabetol
  doi: 10.1186/s12933-020-01186-2
– volume: 21
  start-page: 1539
  year: 2002
  ident: 1268_CR30
  publication-title: Stat Med
  doi: 10.1002/sim.1186
– volume: 20
  start-page: 255
  year: 2003
  ident: 1268_CR35
  publication-title: Diabet Med
  doi: 10.1046/j.1464-5491.2003.00869.x
– volume: 141
  start-page: e139
  year: 2020
  ident: 1268_CR1
  publication-title: Circulation
– volume: 37
  start-page: 1148
  year: 2008
  ident: 1268_CR31
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dyn065
SSID ssj0017861
Score 2.649046
SecondaryResourceType review_article
Snippet Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study evaluated the...
Background Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study...
Abstract Background Insulin resistance has been demonstrated to be involved in the pathogenesis of atherosclerotic cardiovascular diseases (ASCVDs). This study...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 76
SubjectTerms Age
Angina pectoris
Arteriosclerosis
Asymmetry
Atherosclerosis
Atherosclerotic cardiovascular diseases
Cardiovascular disease
Cardiovascular diseases
Cohort analysis
Coronary artery
Coronary artery disease
Coronary vessels
Diabetes
Diabetes mellitus
Glucose
Heart diseases
Insulin
Insulin resistance
Meta-analysis
Original Investigation
Population
Risk factors
Stroke
Triglyceride-glucose index
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Ni9YwEA6yB_Eiftt1lQjepGzSpGnrTcVlEdbTLuwtJNMEhbWVt92D4GH_w_5Df4kzad6XrYhevLZpSTMzmXk6k2cYe2UckGfqSxXpb1UVoWx1EGWH-7EDL3Xs6LzzySdzfKY_ntfnN1p9UU3YQg-8LNyhkBBNAEQVCESciK6XOlSqi16CqOuedl_0eVswlfMHTWvk9ohMaw4n8mqUryToXBk08ZUbSmz9fwoxf6-UvOF6ju6xuzlm5G-Xud5nt8LwgN0-yVnxh-zHKULsi--AytSHn1fXuQydJyZE7oaeY5TH6ad6aiDKx8hT3DdO-LrNiG_lsCpL5TltM73hjn8Nsytd5i6hZ6mn7mbm01KB-IidHX04fX9c5q4KJZiqm0sDovO-7UXnjEaL1EEH1VPbFymCxrUNdewA455K9ACUx_UeKudwMwimbpx6zPaGcQhPGfdBIdyIsVIBtATpDYAJsumVCR0YKJjcLrKFTDlOnS8ubIIerbGLYCwKxibB2K5gr3fPfFsIN_46-h3JbjeSyLLTBVQhm1XI_kuFCnawlbzNFjxZjPuIrB8DvIK93N1G26OEihvCeEljcI9GiKJ0wZ4sirKbCUJ_DAoaVbBmpUKrqa7vDF8-J37vlg5xCrn_P77tGbtTJbXXpVAHbG_eXIbnGEbN_kWymF8KNh4F
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection (NC LIVE)
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Ni9YwEA66gngRv62uEsGblG2aNG29iIrLIqynXXhvJZkkKqzt-rZ7EDz4H_yH_hJn0rzViuy1SUra-c5MnmHsuTZAlsnlMtBpVRkgb5Qv8hb1sQErVGjpvvPxB310qt5vqk06cBtTWeVOJ0ZF7QagM_IDtMMEno4G99X515y6RlF2NbXQuMquEXQZcXW9WQIuUTda7C7KNPpgJNtGWUsKoEuNgr4yRhGz_3-O5r_1kn8ZoMNb7GbyHPnrmdS32RXf32HXj1Nu_C77foK7PfsGyFLO__rxMxWj84iHyE3vOPp6nI7WYxtRPgQevb9hxNdtB3wrh1VxKk_Jm_ElN_yLn0xuEoIJraXOutuJj3Md4j12evju5O1Rnnor5KDLdso1FK21jStaoxXKpfLKS0fNX0ThlfKlr0IL6P2UhQOgbK61UBqDKsHrqjbyPtvrh94_ZNx6iUFHCKX0oAQIqwG0F7WT2regIWNi95M7SMDj1P_irIsBSKO7mTAdEqaLhOnajL1Y1pzPsBuXzn5DtFtmEmR2fDBsP3ZJAnEuBO0Bw1OMaE0RjBP4mbINVkBRVS5j-zvKd0mOx-4P12Xs2TKMEkhpFdP74YLmoKbGQEWqjD2YGWXZiUSHqJS1zFi9YqHVVtcj_edPEeW7oauchXh0-bYesxtlZGiVF3Kf7U3bC_8E3aTJPo2y8BsguxUh
  priority: 102
  providerName: ProQuest
Title Triglyceride–glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies
URI https://www.ncbi.nlm.nih.gov/pubmed/33812373
https://www.proquest.com/docview/2514262617
https://www.proquest.com/docview/2508888234
https://pubmed.ncbi.nlm.nih.gov/PMC8019501
https://doaj.org/article/01cf6ec917094a0fad14e239fb1c055d
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEB_uA457Ofy2ei4RfJNq06RpK4h4csch7CFyC_tW0mlyCmt7dnvg-dc7SdvVyupr80GamcnMLzOZAXihNDrNVIXCutuq2GKYSROFOZ3HGksube7eO88v1PlCflwmyx0Yyx0NG7jeCu1cPalFu3r14_vtOxL4t17gM_V67XSW80Y6YBwrEuBd2CfNlLqKBnP526uQZoqPD2e2jjuEA4JsdJinYqKnfDr_bTbo36GUf-imsztwNBiV7H3PBXdhx9T34GA-uM3vw89LwuCrWyRuq8wYpc58okSm64qREcjcnbuvL8oay7xZ2KxpsrahORlOolbZ4NVZv2GafTOdDvWQ2sSNdSV3246t-wDFB7A4O738cB4ORRdCVHHehQqjvCyzKsq1kiSw0kgjKlcVhkdGShObxOZIZlEcVYjOzVuWGGtNZ4VRSarFQ9irm9o8BlYaQWjE2lgYlBx5qRCV4WkllMlRYQB83OICh4zkrjDGqvDIJFNFT6GCKFR4ChV5AC83Y677fBz_7X3iKLfp6XJp-w9Ne1UMokl90SqDhFsJ6urI6orTb4rclhyjJKkCOB7pXoz8WZBZ6HL5k_0XwPNNM4mm87fo2jQ3rg8d4YRghAzgUc8mm5WMbBZAOmGgyVKnLfXXLz79d-beeEb8yT_nfAqHsWdqGUbiGPa69sY8I9OpK2ewmy7TGeyfnF58-jzzFxAzLyO_APNSGdE
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQw0CpFAi6IZ0kpYCQ4oajxY50ECSFe1ZZ2e9pKewvOxAGkkrSbVKgSB_6B_-Cj-BJmnGQhCPXWazy2HM_bM55h7ImxQJqpCFVJt1WyhDDRLgpTlMcWcqHLlN47zw7M9FC_X0wWa-zn8BaG0ioHmegFdVED3ZFvox6m4umocF8en4TUNYqiq0MLjY4s9tzZV3TZmhe7bxG_T6XceTd_Mw37rgIhGJm2oYEozfOkiFJrNFKkdtqpgtqeiMhp7aSblCmg3pdRAUBxzDwHaS0ygzOT2Cpc9xK7TODk7MWLlYMn4sSI4WFOYrYb0qUUJSWHXRoULCPl53sE_M-w_Tc_8y-Ft3ODXe8tVf6qI62bbM1Vt9iVWR-Lv82-zfF0js4ASbhwv77_6JPfua-_yG1VcLQtOV3l-7alvC65tzbrBpdb1rgqh1EyLO-DRc1zbvkX19rQ9hVTaC518l22vOnyHu-wwws59btsvaord4_x3Cl0cspSKgdagMgNgHEiLpRxKRgImBgOOYO-0Dn12zjKvMOTmKxDTIaIyTxisjRgz1ZzjrsyH-dCvybcrSCpRLf_UC8_Zj3HIyyUxgG6w-hB26i0hcDfVGmZC4gmkyJgWwPms15uNNkfKg_Y49UwcjyFcWzl6lOCQc2AjpHSAdvoCGW1E4UGmFSxClg8IqHRVscj1edPvqp4Qk9HI7F5_rYesavT-Ww_29892LvPrklP3DqM1BZbb5en7gGaaG3-0PMFZx8umhF_AzPQUSQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Triglyceride-glucose+index+and+the+incidence+of+atherosclerotic+cardiovascular+diseases%3A+a+meta-analysis+of+cohort+studies&rft.jtitle=Cardiovascular+diabetology&rft.au=Ding%2C+Xiaobo&rft.au=Wang%2C+Xiaozhen&rft.au=Wu%2C+Jing&rft.au=Zhang%2C+Manli&rft.date=2021-04-03&rft.eissn=1475-2840&rft.volume=20&rft.issue=1&rft.spage=76&rft_id=info:doi/10.1186%2Fs12933-021-01268-9&rft_id=info%3Apmid%2F33812373&rft.externalDocID=33812373
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2840&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2840&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2840&client=summon